|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 23.04 USD | +2.49% |
|
-4.91% | - |
| 09-03 | Latigo Biotherapeutics Q2 Net Loss Narrows | MT |
| 09-01 | Jefferies Initiates Latigo Biotherapeutics at Buy With $50 Price Target | MT |
| Market Cap | 1.46B 1.25B 1.18B 1.08B 2.02B 138B 2.02B 13.94B 5.41B 70.58B 5.47B 5.35B 227B | P/E 2026 * |
-7.65x | P/E 2027 * | -9.94x |
|---|---|---|---|---|---|
| Enterprise Value | 1.11B 952M 896M 818M 1.53B 104B 1.53B 10.59B 4.11B 53.6B 4.15B 4.06B 173B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LTGO | Delayed | |
CBOE
| LTGO | Real-time |
| 1 day | +2.49% | ||
| 1 week | -4.91% | ||
| Current month | +4.63% |
| 1 week | 21.26 |  | 23.85 |
| 1 month | 17.22 | | 25.93 |
| Current year | 17.22 | | 25.93 |
| 1 year | 17.22 | | 25.93 |
| 3 years | 17.22 | | 25.93 |
| 5 years | 17.22 | | 25.93 |
| 10 years | 17.22 | | 25.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bryan Moyer
PRN | Corporate Officer/Principal | - | - |
Nima Farzan
CEO | Chief Executive Officer | 50 | 21/07/2024 |
| Director of Finance/CFO | 39 | 31/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Nima Farzan
BRD | Director/Board Member | 50 | 21/07/2024 |
Timothy Walbert
CHM | Chairman | 59 | 30/09/2024 |
Sara Bonstein
BRD | Director/Board Member | 45 | 31/03/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/08/26 | Westlake Biopartners LLC
| Conversion | Company | 25,390,610 | 40.1509% | |
| 10/08/26 | 5AM Venture Management LLC
| Conversion | Company | 14,651,924 | 23.1695% | |
| 10/08/26 | Foresite Capital Management LLC
| Conversion | Company | 18,222,656 | 28.8160% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.49% | -4.91% | - | - | 1.46B | |
| -2.54% | -2.84% | -1.77% | +14.33% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +46.82% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.83% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -0.58% | -0.01% | +74.05% | +110.25% | 27.65B | |
| Weighted average by Cap. | -1.01% | +0.08% | +89.42% | +128.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -143M -123M -115M -105M -197M -13.46B -198M -1.36B -529M -6.91B -535M -524M -22.25B | -161M -139M -131M -119M -223M -15.22B -224M -1.54B -599M -7.81B -605M -592M -25.16B |
| Net Debt | -351M -302M -284M -259M -485M -33.1B -486M -3.35B -1.3B -16.98B -1.32B -1.29B -54.71B | -215M -185M -174M -159M -298M -20.32B -299M -2.06B -799M -10.42B -808M -790M -33.58B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$23.04 | +2.49% | 227,438 |
| 03/09/26 | US$22.48 | +3.26% | 229,298 |
| 02/09/26 | US$21.77 | -2.20% | 163,228 |
| 01/09/26 | US$22.26 | +1.09% | 288,898 |
| 31/08/26 | US$22.02 | -9.12% | 155,037 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
23.04USD
Average target price
52.25USD
Spread / Average Target
+126.78%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LTGO Stock
Select your edition
All financial news and data tailored to specific country editions
